| Description | Accelerating Access was an initiative to improve HIV/AIDS care and treatment in developing countries. The campaigns aim was to reach agreement between five pharmaceutical companies (Boehringer Ingelheim, Bristol-Myers Squibb, Glaxo Wellcome, Merck & Co., Inc., and F. Hoffman-La Roche) and various NGOs (UNAIDS, United Nations Population Fund (UNFPA), United Nations Children's Fund (UNICEF), WHO and the World Bank)to help enhance the capacity of developing countries to increase the access to and the use of sustainable comprehensive and quality HIV/AIDS interventions across the entire spectrum of prevention, treatment, patient care and support. Papers include minutes, briefing and meeting notes, reports, statements, campaign briefing papers, email correspondence, press releases, newspaper cuttings and report on pilot study from Uganda, that evaluated the effectiveness of UNAIDS Drug Access Initiative (DAI) that was a preceding study before the Accelerating Access campaign. Correspondence includes various letters received from African health ministers about the initiative and background information on the HIV/AIDS work being undertaken by the pharmaceutical companies. |